FDA Seeking Public Comment for COVID-19 mRNA Vaccine for Children
Food and Drug Administration
(News Release) - The Food and Drug Administration (FDA) has established a docket for public comment to seek approval of the Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 mRNA vaccine for administration to children 6 months through 4 years of age.
Docket ID Number FDA-2022-N-0082.
Federal Register Number 2022-02390.
Comments received on or before February 10, 2022, will be provided to the committee. Comments received after February 10, 2022, and by February 14, 2022, will be taken into consideration by FDA.
The docket will close on February 14, 2022. Submit either electronic or written comments on this public meeting by February 14, 2022. Please note that late, untimely filed comments will not be considered.
According to regulation.gov the general function of the committee is to provide advice and recommendations to FDA on regulatory issues.
Click here for more information about how to file a comment.
